Cytokine Storm in the Novel Coronavirus Infection and Methods of its Correction
- 13 February 2021
- journal article
- Published by Publishing House OKI in Antibiotics and Chemotherapy
- Vol. 65 (11-12), 27-37
- https://doi.org/10.37489/0235-2990-2020-65-11-12-27-37
Abstract
The aim of the studywas to identify the role of cytokine storm in COVID-19, that emerged at the end of 2019, based on the analysis of 80 publications, including 17.4% Russian and 82.6% foreign publications for 2014–2020 with an average impact factor of 11.94 and a maximum of 74.699. This review includes an in-depth discussion of the possible causes and pathogenetic factors of cytokine storm syndrome development caused by COVID-19. The results of research on the use of various principles of cytokine storm correction are provided. It has been established that lung damage and the development of a fatal outcome are caused not by the virus itself, but by the hyperreaction of the body's immune system. The leading role in this process belongs to the cytokine storm, including the action of IL-6.Keywords
This publication has 55 references indexed in Scilit:
- Nrf2 signaling pathway: Pivotal roles in inflammationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcriptionNature Communications, 2016
- Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human PrimatesACS Infectious Diseases, 2016
- Single-domain antibodies for biomedical applicationsImmunopharmacology and Immunotoxicology, 2015
- Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis PathwaysThe Journal of Infectious Diseases, 2015
- Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trialThe Lancet Respiratory Medicine, 2015
- Chimeric Antigen Receptor T Cells for Sustained Remissions in LeukemiaThe New England Journal of Medicine, 2014
- Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirusVirology Journal, 2014
- Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseasesCardiovascular Research, 2014
- Is Cholesterol and Amyloid-β Stress Induced CD147 Expression a Protective Response? Evidence that Extracellular Cyclophilin A Mediated Neuroprotection is Reliant on CD147Journal of Alzheimer's Disease, 2014